Tranceptar Technologies was founded in 2011, the company has spread its services in more than 12 countries with 6 of its own global offices spanning from the South & North Americas, Europe, Middle East, North Africa, India and SouthEast Asia.The company though initiated on the background og genetics research has evolved itself in to multiple disciplines with genetics as a blueprint including pharmacology, nutrigenetics, cosmetic genetics, clinical and lifestyle based genetic reports with its own Actionable diagnostics and solutions systems tom enable the healthcare providers worldwide leverage the holistic approach to human health to provide recommendations of Drugs, supplements, food and lifestyle guidelines to patients driving genetic resilience.. The technical team, led by Dr Roberto Grobman has a track record of delivering disruptive technologies and insights based on genetics to the healthcare market.